Search Results - "Loberiza, F. R."

Lenalidomide and cyclophosphamide immunoregulation in patients with metastatic, castration-resistant prostate cancer by Wang, J., McGuire, T. R., Britton, H. C., Schwarz, J. K., Loberiza, F. R., Meza, J. L., Talmadge, J. E.

“…Lenalidomide (LEN) and metronomic cyclophosphamide (CTX) regulate angiogenesis and immunosuppressive cells linked to the progression of metastatic…”
Get full text

Advance care planning among hematopoietic cell transplant patients and bereaved caregivers by Loggers, E T, Lee, S, Chilson, K, Back, A L, Block, S, Loberiza, F R

“…Younger, healthier patients contemplating high-risk (but potentially curative) hematopoietic cell transplants (HCT) may not consider advance care planning…”
Get full text

Pre-transplantation physical and mental functioning is strongly associated with self-reported recovery from stem cell transplantation by ANDORSKY, D. J, LOBERIZA, F. R, LEE, S. J

“…Previous studies of quality of life (QOL) note compromised QOL after stem cell transplantation (HCT), but do not usually consider the impact of…”
Get full text

Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research by Bishop, M R, Logan, B R, Gandham, S, Bolwell, B J, Cahn, J-Y, Lazarus, H M, Litzow, M R, Marks, D I, Wiernik, P H, McCarthy, P L, Russell, J A, Miller, C B, Sierra, J, Milone, G, Keating, A, Loberiza, F R, Giralt, S, Horowitz, M M, Weisdorf, D J

“…For adults with high-risk or recurrent ALL who lack a suitable sibling donor, the decision between autologous (Auto) and unrelated donor (URD) hematopoietic…”
Get full text

Routine screening for psychosocial distress following hematopoietic stem cell transplantation by LEE, S. J, LOBERIZA, F. R, FISHER, D. C, LOGAN, B, SOIFFER, R. J, ANTIN, J. H, KIRKPATRICK, T, PROKOP, L, ALYEA, E. P, CUTLER, C, HO, V. T, RICHARDSON, P. G, SCHLOSSMAN, R. L

“…The diagnosis and treatment of cancer is often associated with high levels of psychosocial distress, yet exploration of these issues is rarely included in…”
Get full text

Factors affecting the development of atrial fibrillation and atrial flutter (AF/AFL) following autologous hematopoietic SCT (auto-HSCT) by Steuter, J A, Villanueva, M L H, Loberiza, F R, Armitage, J O, Bociek, R G, Ganti, A K, Tarantolo, S R, Vose, J M, Easley, A, Bierman, P J

“…The use of autologous hematopoietic SCT (auto-HSCT) has expanded to include older patients. Increasing age is a well-appreciated risk factor for the…”
Get full text

Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR) by LAZARUS, H. M, LOBERIZA, F. R, GIBSON, J, HERZIG, R. H, LEMAISTRE, C. F, MARKS, D, MASON, J, MILLER, A. M, MILONE, G. A, PAVLOVSKY, S, REECE, D. E, RIZZO, J. D, ZHANG, M-J, VAN BESIEN, K, VOSE, J. M, HOROWITZ, M. M, ARMITAGE, J. O, BALLEN, K. K, BASHEY, A, BOLWELL, B. J, BURNS, L. J, FREYTES, C. O, GALE, R. P

“…Although patients with relapsed Hodgkin's disease have a poor prognosis with conventional therapies, high-dose chemotherapy and autologous hematopoietic stem…”
Get full text

Transplant center characteristics and clinical outcomes after hematopoietic stem cell transplantation: what do we know by LOBERIZA, F. R, SERNA, D. S, HOROWITZ, M. M, RIZZO, J. D

“…Center effects are differences in outcome among treatment centers that cannot be explained by identifiable differences in patients treated or specific…”
Get full text

The effect of prostate volume on the yield of needle biopsy by Letran, J L, Meyer, G E, Loberiza, F R, Brawer, M K

“…Early diagnosis of prostate carcinoma has undergone significant evolution mainly due to the widespread use of serum prostate specific antigen, transrectal…”
Get more information

Repeat ultrasound guided prostate needle biopsy: use of free-to-total prostate specific antigen ratio in predicting prostatic carcinoma by Letran, J L, Blase, A B, Loberiza, F R, Meyer, G E, Ransom, S D, Brawer, M K

“…Despite being the most useful tumor marker for the diagnosis of patients with prostate cancer, serum prostate specific antigen (PSA) is still hampered by lack…”
Get more information

Is there a place for routine imaging for patients in complete remission from aggressive lymphoma? by Armitage, J.O., Loberiza, F.R.

Get full text

Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation by CHAMPLIN, R. E, SCHMITZ, N, KLEIN, J. P, MONTSERRAT, E, ZHANG, M.-J, RINGDEN, O, TOMANY, S. C, ROWLINGS, P. A, VAN HOEF, M. E. H. M, GRATWOHL, A, HOROWITZ, M. M, CHAPUIS, B, CHOPRA, R, CORNELISSEN, J. J, GALE, R. P, GOLDMAN, J. M, LOBERIZA, F. R, HERTENSTEIN, B

Get full text

Flow-induced dilation of human coronary arterioles: important role of Ca(2+)-activated K(+) channels by Miura, H, Wachtel, R E, Liu, Y, Loberiza, Jr, F R, Saito, T, Miura, M, Gutterman, D D

“…Flow-induced vasodilation (FID) is a physiological mechanism for regulating coronary flow and is mediated largely by nitric oxide (NO) in animals. Because…”
Get full text

Initial Results, Reliability, and Validity of a Mental Health Survey of Mount Pinatubo Disaster Victims by HOWARD, WILLIAM T, LOBERIZA, FAUSTO R, PFOHL, BRUCE M, THORNE, PETER S, MAGPANTAY, RIO L, WOOLSON, ROBERT F

“…This report presents the initial results of a mental health survey of 351 tribal and non-tribal Mount Pinatubo disaster victims 6 years after they were…”
Get full text

Diabetes Mellitus Impairs Vasodilation to Hypoxia in Human Coronary Arterioles: Reduced Activity of ATP-Sensitive Potassium Channels by Miura, Hiroto, Wachtel, Ruth E, Loberiza, Fausto R, Saito, Takashi, Miura, Mamoru, Nicolosi, Alfred C, Gutterman, David D

“…ABSTRACT—ATP-sensitive K channels (KATP) contribute to vasomotor regulation in some species. It is not fully understood the extent to which KATP participate in…”
Get full text

Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT) by Champlin, R E, Schmitz, N, Horowitz, M M, Chapuis, B, Chopra, R, Cornelissen, J J, Gale, R P, Goldman, J M, Loberiza, Jr, F R, Hertenstein, B, Klein, J P, Montserrat, E, Zhang, M J, Ringdén, O, Tomany, S C, Rowlings, P A, Van Hoef, M E, Gratwohl, A

“…Peripheral blood cells are increasingly used in place of bone marrow as a source of hematopoietic stem cells for allogeneic transplantation. The relative…”
Get full text

The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase by Lee, Stephanie J., Klein, John P., Anasetti, Claudio, Antin, Joseph H., Loberiza, Fausto R., Bolwell, Brian J., LeMaistre, Charles F., Litzow, Mark R., Marks, David, Waller, Edmund K., Matlack, Marie, Giralt, Sergio, Horowitz, Mary M.

“…Various therapeutic options are available for patients with chronic myelogenous leukemia. Allogeneic stem cell transplantation, though often curative, is…”
Get full text

Transplant registries: guiding clinical decisions and improving outcomes by Horowitz, M M, Loberiza, F R, Bredeson, C N, Rizzo, J D, Nugent, M L

“…About 50,000 hematopoietic stem cell transplantations are performed yearly, primarily for malignancies. Use of this therapy increased dramatically over the…”
Get more information

Outcomes of patients with stage III (clinical N2) NSCLC: A VACCR analysis by Ganti, A., Gonsalves, W., Aldoss, I., Loberiza, F. R.

“…Abstract only…”
Get full text

Compliance with ASCO guidelines in the treatment of stage IV non-small cell lung cancer by Marr, A. S., Loberiza, F. R., Kessinger, M. A., McGarry, J., Ganti, A. K.

“…Abstract only…”
Get full text